Meeting people where they are with personalized AI-powered patient outreach could help traditional healthcare move beyond reactive medicine. The post Could AI be the Antidote to ‘Sick Care’ in America? appeared first on MedCity News.
A small Tennessee hospital that was destroyed by a surging river during Hurricane Helene will soon be rebuilt on low-lying farmland that could face several feet of flooding in a much smaller storm, risking another disaster if the new facility is not built to withstand extreme weather, according to a KFF Health News analysis. Ballad…
Rebekah Stewart, a nurse at the U.S. Public Health Service, got a call last April that brought her to tears. She had been selected for deployment to the Trump administration’s new immigration detention operation at Guantánamo Bay, Cuba. This posting combined Donald Trump’s longtime passion to use the offshore base to move “some bad dudes”…
Republicans have hitched themselves to the “Make America Healthy Again” campaign, banking on its popularity to give them an electoral bounce. But the strategy carries risks. Health and Human Services Secretary Robert F. Kennedy Jr., a longtime anti-vaccine activist who rails against Big Pharma and ultraprocessed food, is the leader of the movement. And Americans’…
OpenEvidence’s $12 billion valuation reflects investor confidence in its bottom-up, doctor-first model. It has driven rapid adoption, with more than 430,000 clinicians using the startup’s free AI medical search tool regularly. That scale is paired with targeted pharmaceutical advertising that’s already pushed the company past a $100 million revenue run rate. The post Thunderstruck By…
The Consolidated Appropriations Act of 2026 and the Department of Labor’s proposed rule implement major PBM reforms for employers, but don’t include everything they want, including a ban on spread pricing. The post Employers Celebrated PBM Reform. The Reality Is More Complicated appeared first on MedCity News.
Brepocitinib is on track for pivotal testing after meeting the goals of a proof-of-concept study in cutaneous sarcoidosis, a rare inflammatory skin disorder with no FDA-approved therapies. Roivant Sciences subsidiary Priovant Therapeutics licensed the dual JAK1 and TYK2 inhibitor from Pfizer. The post Clinical Trial Win Bolsters Blockbuster Prospects for Roivant Rare Disease Drug Licensed…
We now have technology that can address the problems faced by so many rural hospitals, improving both patient outcomes and an organization’s bottom line. The post It Doesn’t All Have to Be Doom and Gloom for Rural Hospitals – A Blueprint for Improving Cost Structures appeared first on MedCity News.
The CEO of the Israeli company believes the company has a superior, minimally invasive product that is designed to be a permanent implant, though the procedure is fully reversible. The post Butterfly Medical Offers Non-Surgical Option to Treat Enlarged Prostate appeared first on MedCity News.
More brokers are introducing medical gap insurance, more employers are adopting it, and more employees are benefiting from the added protection. The next step is making sure awareness keeps pace with need. The post Medical Gap Insurance Adoption is on the Rise: Closing Coverage and Knowledge Gaps for Employers appeared first on MedCity News.